CME Group Past Earnings Performance
Past criteria checks 5/6
CME Group has been growing earnings at an average annual rate of 10.5%, while the Capital Markets industry saw earnings growing at 3% annually. Revenues have been growing at an average rate of 2.6% per year. CME Group's return on equity is 11.8%, and it has net margins of 56.2%.
Key information
10.5%
Earnings growth rate
10.1%
EPS growth rate
| Capital Markets Industry Growth | 5.2% |
| Revenue growth rate | 2.6% |
| Return on equity | 11.8% |
| Net Margin | 56.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How CME Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 5,616 | 3,157 | 1,577 | 0 |
| 31 Dec 23 | 5,569 | 3,186 | 1,570 | 0 |
| 30 Sep 23 | 5,338 | 3,011 | 1,536 | 0 |
| 30 Jun 23 | 5,228 | 2,942 | 1,519 | 0 |
| 31 Mar 23 | 5,104 | 2,828 | 1,491 | 0 |
| 31 Dec 22 | 5,009 | 2,657 | 1,456 | 0 |
| 30 Sep 22 | 4,833 | 2,633 | 1,443 | 0 |
| 30 Jun 22 | 4,715 | 2,889 | 1,440 | 0 |
| 31 Mar 22 | 4,657 | 2,745 | 1,448 | 0 |
| 31 Dec 21 | 4,690 | 2,617 | 1,418 | 0 |
| 30 Sep 21 | 4,630 | 2,435 | 1,521 | 0 |
| 30 Jun 21 | 4,600 | 1,920 | 1,543 | 0 |
| 31 Mar 21 | 4,603 | 1,913 | 1,564 | 0 |
| 31 Dec 20 | 4,884 | 2,105 | 1,491 | 0 |
| 30 Sep 20 | 4,911 | 2,151 | 1,545 | 0 |
| 30 Jun 20 | 5,109 | 2,375 | 1,539 | 0 |
| 31 Mar 20 | 5,200 | 2,386 | 1,532 | 0 |
| 31 Dec 19 | 4,868 | 2,117 | 1,447 | 0 |
| 30 Sep 19 | 4,959 | 2,033 | 1,518 | 0 |
| 30 Jun 19 | 4,588 | 1,808 | 1,370 | 0 |
| 31 Mar 19 | 4,377 | 1,860 | 1,235 | 0 |
| 31 Dec 18 | 4,309 | 1,962 | 1,126 | 0 |
| 30 Sep 18 | 3,973 | 4,516 | 977 | 0 |
| 30 Jun 18 | 3,959 | 4,413 | 996 | 0 |
| 31 Mar 18 | 3,824 | 4,262 | 993 | 0 |
| 31 Dec 17 | 3,645 | 4,063 | 929 | 0 |
| 30 Sep 17 | 3,658 | 1,498 | 1,014 | 0 |
| 30 Jun 17 | 3,609 | 1,662 | 1,000 | 0 |
| 31 Mar 17 | 3,590 | 1,566 | 1,008 | 0 |
| 31 Dec 16 | 3,595 | 1,534 | 971 | 0 |
| 30 Sep 16 | 3,496 | 1,452 | 984 | 0 |
| 30 Jun 16 | 3,505 | 1,340 | 994 | 0 |
| 31 Mar 16 | 3,418 | 1,284 | 986 | 0 |
| 31 Dec 15 | 3,327 | 1,247 | 985 | 0 |
| 30 Sep 15 | 3,354 | 1,262 | 998 | 0 |
| 30 Jun 15 | 3,266 | 1,192 | 985 | 0 |
| 31 Mar 15 | 3,178 | 1,191 | 990 | 0 |
| 31 Dec 14 | 3,113 | 1,127 | 982 | 0 |
| 30 Sep 14 | 2,958 | 1,014 | 964 | 0 |
| 30 Jun 14 | 2,911 | 960 | 965 | 0 |
| 31 Mar 14 | 2,990 | 1,008 | 941 | 0 |
| 31 Dec 13 | 2,931 | 977 | 914 | 0 |
| 30 Sep 13 | 2,905 | 951 | 877 | 0 |
| 30 Jun 13 | 2,874 | 932 | 844 | 0 |
Quality Earnings: CME * has high quality earnings.
Growing Profit Margin: CME *'s current net profit margins (56.2%) are higher than last year (55.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CME *'s earnings have grown by 10.5% per year over the past 5 years.
Accelerating Growth: CME *'s earnings growth over the past year (11.6%) exceeds its 5-year average (10.5% per year).
Earnings vs Industry: CME * earnings growth over the past year (11.6%) exceeded the Capital Markets industry 3.6%.
Return on Equity
High ROE: CME *'s Return on Equity (11.8%) is considered low.